OBESITY, ABDOMINAL
Clinical trials for OBESITY, ABDOMINAL explained in plain language.
Never miss a new study
Get alerted when new OBESITY, ABDOMINAL trials appear
Sign up with your email to follow new studies for OBESITY, ABDOMINAL, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Workplace soda ban plus counseling shows promise for weight loss
Disease control CompletedThis study tested whether removing sugary drinks from hospital workplaces and offering brief counseling could help employees lose belly fat and improve insulin sensitivity. Over 600 full-time workers who drank at least three sugary beverages per week took part. The main measures …
Matched conditions: OBESITY, ABDOMINAL
Phase: NA • Sponsor: University of California, San Francisco • Aim: Disease control
Last updated May 26, 2026 05:50 UTC
-
Fatty liver breakthrough? drug targets hormone to shrink liver fat
Disease control CompletedThis study tested a drug called tesamorelin in 51 obese adults with nonalcoholic fatty liver disease (NAFLD). The drug aims to boost growth hormone levels, which may reduce liver fat and inflammation. Researchers measured liver fat with special scans and biopsies to see if the tr…
Matched conditions: OBESITY, ABDOMINAL
Phase: PHASE2 • Sponsor: Massachusetts General Hospital • Aim: Disease control
Last updated May 22, 2026 13:50 UTC